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Platelet lysate (PL) is a class of platelet-rich hemoderivatives produced by cryogenic disruption of 
platelet concentrates, originating a pool of supra-physiological concentrations of growth factors (GFs) 
that is being widely explored in the medical field, namely in sports medicine and orthopaedics. In this 
concern, patch augmentation strategies have been receiving increased attention as the basis for the 
development of novel biomaterials aiming at tendon regeneration. In the present work, we assessed PL-
membranes as prospective bioinstructive patches under the hypothesis that tendon cells positively 
respond to PL-derived biochemical signals. 
For this purpose, PL membranes were fabricated as previously described by Babo et al1 and 
characterized in terms of degradation, PL-derived proteins and GF release profiles. Cell behaviour was 
studied in terms of metabolic activity and proliferation, as well as extracellular matrix (ECM) production 
by culturing human tendon-derived cells (hTDCs) up to 21 days. In addition, the potential of PL 
membranes as antibacterial surfaces for biomedical implants was evaluated against Staphylococcus 
aureus ATCC 29213 by determining the number of viable counts, as well as biofilm formation and 
distribution up to 72h, using PDMS films as controls. 
Overall, our results showed that PL membranes remained stable for up to 30 days in PBS. In addition, 
PL-derived proteins, as well as specific GFs like basic fibroblast growth factor (bFGF) and platelet 
derived growth factor (PDGF)-BB followed a typical controlled release profile, as described by Babo et 
al1. Regarding the biological performance, PL-membranes were able to control the proliferation of 
seeded hTDCs, as demonstrated by maintenance of DNA content over 21 days of culture, in comparison 
to the controls in standard culture plastic. This result strongly suggests that PL-membranes can avoid 
an extensive proliferative phase, which in vivo is responsible for the formation of scar tissue, a major 
concern during tendon healing. These cells were metabolically active over time in culture and deposited 
tendon-related ECM proteins, including collagen types 1 and 3 and tenascin-C. Additionally, PL-
membranes exhibited a significantly reduced number of viable counts of S. aureus, together with 
diminished bacteria adherence after 24h of incubation. No biofilm formation was observed in comparison 
to PDMS controls. 
Altogether, our results demonstrate that these PL-membranes can modulate cellular activity in situ, 
acting as a reservoir of bioactive molecules derived from PL, which supports their application as 
bioinstructive and protective patches for tendon regeneration. Finally, exploring the multitude of features 
of crosslinked PL proteins can potentially uncover uncharted prospective applications in regenerative 
medicine. 
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